PMID: 6104319Feb 1, 1980Paper

Pharmacology of ocular drugs. 1. Timolol maleate

Ophthalmology
H E Kaufman

Abstract

Timolol maleate is a new, potent ocular antihypertensive that has an effect additive with other antiglaucoma medications. It does not cause miosis and is relatively free of ocular complications, although a few have been documented. Timolol does exacerbate asthma and should not be used in patients with a history of this disease. It should be used with caution in cases of significant cardiovascular disease and may produce occasional psychic disturbances. In general, timolol is a potent, effective, and relatively safe drug with few ocular side effects but should be used with appropriate care.

References

Jan 1, 1978·The Journal of Pharmacy and Pharmacology·P VermeijP A van Zwieten
Nov 1, 1978·Archives of Ophthalmology·R L Coakes, R F Brubaker
Aug 2, 1979·The New England Journal of Medicine·C J Diskin
Jul 1, 1979·American Journal of Ophthalmology·R J OlsonT J Zimmerman
Oct 26, 1979·JAMA : the Journal of the American Medical Association·R P Wilson, G L Spaeth
Oct 1, 1979·American Journal of Ophthalmology·C D McMahonJ Hetherington
Oct 1, 1979·American Journal of Ophthalmology·E M Van Buskirk

❮ Previous
Next ❯

Citations

Feb 29, 1984·Documenta Ophthalmologica. Advances in Ophthalmology·D SpinelliP Montanari
Aug 1, 1996·Ophthalmology·A J Flach
Oct 17, 1998·Cancer Investigation·J P McGowan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
A T van Balen
Journal of Neurology, Neurosurgery, and Psychiatry
A C Reid, J A Thomson
© 2021 Meta ULC. All rights reserved